Paweł Gunerka
Paweł Gunerka publishes mostly in Molecular Biology, Oncology and Genetics, on topics such as Cytokine Signaling Pathways and Interactions, PI3K/AKT/mTOR signaling in cancer and Chronic Lymphocytic Leukemia Research.
- World rank
- #5,615,217 of 7,710,434 ranked researchers
- Rank in Poland
- #51,688 of 100,960
- Works
- 20
- Citations
- 171
- Citations per work
- 8.6
What does Paweł Gunerka research?
Paweł Gunerka's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences842.3%
- Medicine842.3%
- Everything else630.7%
- Life Sciences421.2%
- Physical Sciences15.8%
- Chemistry15.8%
- 1Molecular Biology21% of their works
- 2Oncology19% of their works
- 3Genetics12% of their works
- 4Organic Chemistry6% of their works
- 5Hematology6% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Cytokine Signaling Pathways and Interactions
- PI3K/AKT/mTOR signaling in cancer
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Lung Cancer Treatments and Mutations
- Lymphoma Diagnosis and Treatment
- Asthma and respiratory diseases
Which keywords describe Paweł Gunerka's research?
The keywords of their largest research topics: Cancer, Inflammation, IL-6, STAT3, Rituximab, mTOR, Signaling and BCR-ABL.
- Classification
- Allergic Diseases
- Myelofibrosis
- Imatinib
- EGFR Mutations
- BCR-ABL
- Signaling
- STAT3
- Inflammation
- Cancer
- IL-6
- Rituximab
- mTOR
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- JAK2 Mutation
- Targeted Therapy
- Asthma
- Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cancer122 topics
- Inflammation102 topics
- IL-681 topic
- STAT381 topic
- Rituximab52 topics
- Signaling41 topic
- mTOR41 topic
- BCR-ABL31 topic
- Chronic Lymphocytic Leukemia31 topic
- EGFR Mutations31 topic
- Genomic Aberrations31 topic
- Imatinib31 topic
- JAK2 Mutation31 topic
- Myelofibrosis31 topic
- Targeted Therapy31 topic
- Allergic Diseases21 topic
- Asthma21 topic
- Classification21 topic
- Lymphoma21 topic
Where does Paweł Gunerka work?
Paweł Gunerka's main affiliation in the publication record is Celon Pharma (Poland), Poland.
How many publications and citations does Paweł Gunerka have?
OpenAlex counts 20 works and 171 citations for Paweł Gunerka, an h-index of 7, ranking #5,615,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paweł Gunerka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.